Pharmacy and Poisons Board recalls cancer drug over safety

The Pharmacy and Poisons Board has warned against using the cancer drug Flurasted 500 from Batch Number HHP24017, citing safety concerns.

In a statement posted on X on Thursday, the Board urged the public to cease using the drug immediately and to report any related issues.

“All pharmaceutical outlets, healthcare facilities, healthcare professionals, and members of the public are directed to quarantine the affected batch immediately and halt its distribution, sale, issuance, or use,” the statement read.

The Board’s CEO, Fred Siyoi, explained that a market complaint regarding the appearance of the drug prompted the action.

.

Keep Reading business

•  End of an era as Mastermind Tobacco to go under the hammer
•  Irony of lowest inflation in 17 years but Kenyans barely making ends meet
•  2024: Year of layoffs as businesses struggle to stay afloat
•  Honda and Nissan expected to begin merger talks
•  How new KRA guidelines will impact income tax calculation

The public is encouraged to report suspected cases of substandard medicines or adverse drug reactions to the nearest healthcare facility or directly to the Pharmacy and Poisons Board.